GNG10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.857400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.340200E-01
Normal-vs-Stage2
6.868000E-01
Normal-vs-Stage3
4.638000E-01
Normal-vs-Stage4
8.236000E-01
Stage1-vs-Stage2
4.663600E-01
Stage1-vs-Stage3
3.176600E-01
Stage1-vs-Stage4
7.074400E-01
Stage2-vs-Stage3
4.315600E-01
Stage2-vs-Stage4
9.252600E-01
Stage3-vs-Stage4
5.133600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.755400E-01
Normal-vs-AfricanAmerican
7.054600E-01
Normal-vs-Asian
9.078600E-01
Caucasian-vs-AfricanAmerican
7.715000E-01
Caucasian-vs-Asian
7.512800E-01
AfricanAmerican-vs-Asian
6.299000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.700400E-01
Normal-vs-Female
9.437000E-01
Male-vs-Female
1.917050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.631000E-01
Normal-vs-Age(41-60Yrs)
7.544200E-01
Normal-vs-Age(61-80Yrs)
6.148400E-01
Normal-vs-Age(81-100Yrs)
3.732200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.822200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.836600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.351000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.844200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.199900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.201000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.849200E-01
Normal-vs-Daily Drinker
7.269200E-01
Normal-vs-Weekly Drinker
9.107000E-01
Normal-vs-Occasional Drinker
9.709800E-01
Normal-vs-Social Drinker
6.811000E-01
Non Drinker-vs-Daily Drinker
4.139600E-01
Non Drinker-vs-Weekly Drinker
2.719200E-01
Non Drinker-vs-Occasional Drinker
1.515770E-01
Non Drinker-vs-Social Drinker
6.039600E-01
Daily Drinker-vs-Weekly Drinker
6.824200E-01
Daily Drinker-vs-Occasional Drinker
4.772000E-01
Daily Drinker-vs-Social Drinker
8.506000E-01
Weekly Drinker-vs-Occasional Drinker
7.955400E-01
Weekly Drinker-vs-Social Drinker
5.992400E-01
Occasional Drinker-vs-Social Drinker
4.365800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.083400E-01
Normal-vs-Grade 2
9.208200E-01
Normal-vs-Grade 3
8.584400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.992200E-01
Grade 1-vs-Grade 3
3.361600E-01
Grade 1-vs-Grade 4
9.083400E-01
Grade 2-vs-Grade 3
1.178390E-01
Grade 2-vs-Grade 4
9.208200E-01
Grade 3-vs-Grade 4
8.584400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.521800E-01
Normal-vs-NonDiabetic
8.403000E-01
Diabetic-vs-NonDiabetic
1.004840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.977800E-01
Normal-vs-NoPancreatitis
8.174200E-01
Pancreatitis-vs-NoPancreatitis
1.135420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.614600E-01
Normal-vs-N1
6.953000E-01
N0-vs-N1
2.714400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.679000E-01
Normal-vs-TP53-NonMutant
4.369000E-01
TP53-Mutant-vs-TP53-NonMutant
3.077400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
